Brief: NewLink Genetics Corp, Cyclone Merger Sub And Lumos Pharma Enter Into Amendment No.1 To Agreement And Plan Of Merger And Reorganization

Lumos Pharma

20/11/2019 12:09

Nov 20 (Reuters) - NewLink Genetics Corp  NLNK.O :
    * NEWLINK GENETICS -  CO, CYCLONE MERGER SUB & LUMOS PHARMA
ENTERED INTO AMENDMENT NO. 1 TO AGREEMENT AND PLAN OF MERGER &
REORGANIZATION
    * NEWLINK GENETICS - MERGER AGREEMENT AMENDMENT EXTENDS
TIMING TO
FILE PRELIMINARY PROXY STATEMENT WITH SEC TO WITHIN 53 DAYS
AFTER MERGER AGREEMENT
    * NEWLINK GENETICS - AMENDMENT PROVIDES AFTER EFFECTIVE TIME
CO
WILL HAVE A 6 MEMBER BOARD & WILL APPOINT SEVENTH MEMBER AFTER
CLOSING OF TRANSACTIONS

Source text: [ID: https://bit.ly/37nzA3a]
Further company coverage:  NLNK.O 

 ((Reuters.Briefs@thomsonreuters.com;))